HCID 13656054, compound → HCID 20164133, compound
Reaction equation
O1[C:5]2([CH2:10][CH2:9][N:8]([C:11]3[CH:12]=[C:13]4[C:22](=[CH:23][CH:24]=3)[C:16]3=[N:17][NH:18][C:19](=[O:21])[CH2:20][CH:15]3[CH2:14]4)[CH2:7][CH2:6]2)[O:4]CC1.N1(C2C=C3C(=CC=2)C2=NNC(=O)C=C2C3)C=CN=C1>>[OH:4][CH:5]1[CH2:6][CH2:7][N:8]([C:11]2[CH:12]=[C:13]3[C:22](=[CH:23][CH:24]=2)[C:16]2=[N:17][NH:18][C:19](=[O:21])[CH2:20][CH:15]2[CH2:14]3)[CH2:9][CH2:10]1Participants
3
Procedure
2,4,4a,5-tetrahydro-7-(1,4-dioxa-8-azaspiro[4,5]dec-8-yl)-3H-indeno[1,2-c]pyridazin-3-one, and 2,5-dihydro-7-(1H-imidazol-1-yl)-3H-indeno[1,2-c]pyridazin-3-one.
Sources & evidence
- ORD record
- ord-6bfdd2a378e446b78161467224dbcc48
- Source dataset
- uspto-grants-1986_07
- Patent number
- US04602019
Reaction notes
Loading…